Abstract Insulin receptor substrates (IRS)-1 and -2 are major substrates of insulin and type I insulin-like growth factor (IGF-I) receptor (IGF-IR) signaling. In this study, SH-EP human neuroblastoma cells are used as a model system to examine the differential roles of IRS-1 and IRS-2 on glucose-mediated apoptosis. In the presence of high glucose, IRS-1 underwent caspase-mediated degradation, followed by focal adhesion kinase (FAK) and Akt degradation and apoptosis. IRS-2 expression blocked all these changes whereas IRS-1 overexpression had no effect. In parallel, IRS-2, but not IRS-1, overexpression enhanced IGF-I-mediated Akt activation without affecting extracellular regulated kinase signaling. While IRS-1 was readily degraded by caspases, hyperglycemia-mediated IRS-2 degradation was unaffected by caspase inhibitors but blocked by proteasome and calpain inhibitors. Our data suggest that the differential degradation of IRS-1 and IRS-2 contributes to their distinct modes of action and the increased neuroprotective effects of IRS-2 in this report are due, in part, to its resistance to caspase-mediated degradation.
Introduction
Insulin-like growth factor-I (IGF-I) plays crucial roles in the regulation of growth, survival, and normal metabolism of many cell types [1] . IGF signaling plays important roles in the malignant transformation of many tumors, including neuroblastoma [2] . Most of the physiological effects of IGF-I are mediated by the type I IGF receptor (IGF-IR) [3] . Ligand binding of IGF-IR causes IGF-IR autophosphorylation, which subsequently initiates the binding of specific docking molecules to the phosphorylated receptor. One such docking molecule is insulin receptor substrate (IRS), which binds to phosphotyrosine residues on IGF-IR b-subunits. Receptor-IRS binding is required for IGF-Imediated downstream signal transduction [4] .
The most thoroughly characterized members of the IRS protein family are IRS-1 and IRS-2. Even though they display similar structural and functional characteristics, IRS-1 and IRS-2 mediate distinctly different cellular responses. IRS-2 knockout mice, but not IRS-1 deficient mice, develop diabetes [5, 6] , and disruption of the IRS-2 gene results in reduced neuronal proliferation and impaired brain growth [7] . In hepatocellular carcinoma, IRS-1 mediates the mitogenic effects of IGF-I [8] , whereas IRS-2 is responsible for the metabolic and anti-apoptotic effects of insulin in adult and neonatal hepatocytes [6, 9] . IRS-1 and IRS-2 also have differential roles during serum deprivation-induced apoptosis in pre-adipocytes [10] and activation-induced cell death in T cell hybridomas [11] . Collectively, these reports suggest that IRS-1 and IRS-2 may have unique roles for cell survival and proliferation.
Our laboratory studies the regulation of apoptosis in primary and transformed neuronal cells. High concentrations of glucose or mannitol induce apoptotic cell death in primary dorsal root ganglia (DRG) neurons and glia, and in SH-SY5Y and SH-EP human neuroblastoma (NBL) cells [12] [13] [14] . Apoptosis in SH-EP cells is accompanied by dephosphorylation and degradation of focal adhesion kinase (FAK) and Akt, disruption of actin stress fibers, loss of focal adhesion sites, and cell detachment, all of which are prevented by IGF-I treatment, overexpression of IGF-IR [13, 15] or caspase inhibition [16] . We previously reported differential expression of IGF-IR and IRS in NBL cells. SH-EP cells express low levels of IGF-IR and IRS-2 and high levels of IRS-1. In contrast, SH-SY5Y cells express high levels of IGF-IR and IRS-2 and virtually no IRS-1. By transfecting SH-SY5Y cells with IRS-1 and SH-EP cells with IRS-2, we demonstrated that the differential regulation of IRS proteins by IGF-I is a key pathway modulating IGF-IR signaling in NBL cells [17] .
Neuroblastoma is the most common solid tumor found in children and accounts for 7-10% of pediatric malignancies [18] , with most cases detected in children younger than 10 years of age [19] . Unfortunately, less than 20% of highgrade neuroblastoma patients survive despite the currently available chemotherapeutic and radiation therapies [20] . While most solid tumors respond to chemotherapeutic agents by undergoing apoptosis [21] , neuroblastoma is frequently chemoresistant. To further define the development of apoptosis, we examined the differential roles of IRS-1 and IRS-2 in neuroblastoma, using SH-EP NBL cells as a model system. In this report we show evidence suggesting that differential resistance to degradation by proteases may contribute to the unique protective role of IRS-2 in neuronal cells.
Experimental procedures

Materials
Anti-IRS-1, anti-IRS-2, anti-FAK, anti-HA, anti-p85, antiShc, and anti-actin antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Antibodies against total and phosphorylated forms of Akt and extracellular regulated kinase 1 and 2 (ERK1/2), and caspase-3 were purchased from Cell Signaling Technology (Beverly, MA). MG132 and calpain inhibitor III were purchased from Calbiochem (La Jolla, CA). General caspase inhibitor, ZVAD, was purchased from Biomol (Plymouth Meeting, PA). Recombinant human IGF-I was kindly provided by Cephalon, Inc. (Westchester, PA). HA-tagged IRS-1 and IRS-2 containing vectors were kindly provided by Dr. D. Yee of the University of Minnesota [22] .
Cell culture SH-EP and SH-SY5Y human NBL cells were maintained in DMEM containing 10% calf serum. HA-tagged IRS-1 and IRS-2 containing vectors or empty pcDNA vectors were transfected into NBL cells using Lipofectamine 2000 reagent (Invitrogen Life Technology, Carlsbad, CA) according to the manufacturer's protocol. Transfected cells were maintained in DMEM containing 10% calf serum and 0.25 mg/ml G418 (Invitrogen Life Technology). The cells were serum starved 4-6 h before treatment. The inhibitors were added with glucose treatment. IRS-2 siRNA was purchased from Dharmacon (Chicago, IL). SH-SY5Y cells were transfected with 150 nM siRNA using Lipofectamine 2000 reagent for 96 h before treatment.
Flow cytometry
Hypodiploid (sub-G o ) apoptotic analyses of SH-EP transfectants were performed in triplicate using propidium iodide as previously described [13] . Briefly, cells were serum starved overnight, treated with or without 300 mM glucose for 2, 4, or 8 h and collected. Cells were fixed using 70% ice cold ethanol and stained with 18 lg/ml propidium iodide containing 40 lg/ml RNase A. The percent apoptotic cells representing the sub-G o fraction was determined using an Epics flow cytometry system (Coulter Cytometry, Hialeah, FL).
Western immunoblotting
Western immunoblotting and immunoprecipitation were performed as described previously [23] . After treatment, the cells were lysed by incubation on ice for 5 min with modified RIPA buffer (20 mM Tris, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, and 1% Triton X-100) with 1 lg/ml of aprotinin and leupeptin and 1 mg/ml of NaOV and PMSF. The cell lysates were centrifuged at 13,000 rpm for 20 min at 4°C, and the supernatants were collected. The protein concentration was measured by DC protein assay reagent (Bio-Rad, Hercules, CA). Equal amounts of protein were separated by SDS-PAGE and transferred to nitrocellulose (NC) membrane. After blocking with 5% skim-milk in TBS with 0.1% Tween-20, the NC membrane was incubated with appropriate primary antibodies followed by secondary antibodies conjugated with horseradish peroxidase. The signal was visualized using enhanced chemiluminescence reagents (Amersham Bioscience, Piscataway, NJ). In some experiments, the NC membranes were incubated at 70°C for 30 min in stripping solution (2% SDS, 100 mM dithiothreitol and 100 mM Tris, pH 6.8) whereupon they were utilized for immunoblotting with another antibody. All experiments were repeated at least three times, and representative results are presented in the figures.
Results
IRS-2, but not IRS-1, transfection protects SH-EP cells from glucose-induced apoptosis
We previously described IGF-I:IGF-IR signaling in N and S type NBL cells [24] including differential expression of IGF-IR, IRS-1, and IRS-2. We also reported the transfection of IRS-1 and IRS-2 into S and N cells, respectively, and their differential regulation by IGF-I treatment [25] . In this report, the role of IRS proteins in mediating IGF-IR protection of neural cells against glucose-induced apoptosis was investigated using SH-EP cells (expressing high levels of endogenous IRS-1 but low levels of IGF-IR and IRS-2) transfected with HA-tagged IRS-2. First, vector (pcDNA3.1) or HA-IRS-2 transfected SH-EP cells are serum starved, treated with 300 mM glucose for 0-8 h, and stained with propidium iodide to measure sub G 0 DNA, indicative of apoptosis. In agreement with our previous reports [12, 13, 15, 16] , glucose treatment results in timedependent apoptosis in vector transfected cells (Fig. 1a) . IRS-2 transfection significantly (P \ 0.02) protects SH-EP cells from glucose-induced apoptosis at all time points (Fig. 1a) . SH-SY5Y cells express high levels of endogenous IGF-IR and IRS-2 but virtually no IRS-1 [24] . We demonstrated the different expression and specific roles of IGF-IR and its downstream signaling pathways. SH-SY5Y and SH-EP cells also demonstrated different expression of Shc, FAK, paxillin, Akt, and ERK [24] . Our laboratory demonstrated that these signaling pathways play important roles in cell survival [12, 24, 26, 27] , making SH-SY5Y cells intrinsically more resistant to apoptosis. Glucose treatment of vector-transfected SH-SY5Y cells induces a 34% increase in apoptosis over DMEM treatment (compared to a 431% increase in SH-EP cells). IRS-1 transfection into SH-SY5Y cells slightly decreases apoptosis, but the data do not reach statistical significance (Fig. 1b) .
Caspases are important mediators of apoptosis [28] ; they are synthesized as inactive precursors and proteolytically cleaved to generate active enzymes. When SH-EP/vector cells are treated with 300 mM glucose, there is a timedependent cleavage of caspase-3 ( Fig. 1c) , which precedes the detection of apoptosis. Increased expression of cleaved caspase-3 was accompanied by the simultaneous decrease in total caspase-3 bands. IRS-2 transfection prevents caspase-3 cleavage by glucose treatment (Fig. 1c) .
To examine whether the above results are specific to IRS-2 or a general transfection of IRS proteins, we overexpressed HA-tagged IRS-1 in SH-EP cells. Anti-HA immunoblotting demonstrates that transfection of IRS-1 or IRS-2 does not affect the endogenous levels of IRS-1 or other molecules involved in IGF-IR signaling such as Shc or p85 (Fig. 2a) . Even though IRS-1 transfection results in statistically significant protection against glucose-induced apoptosis, the effect is much less efficient than IRS-2 transfection (27% protection for IRS-1 transfected cells vs. 76% protection for IRS-2 transfected cells) (Fig. 2b) . IRS-1 transfection does not prevent the cleavage of caspase-3 (Fig. 2c) . Both vector and IRS-1 transfected cells demonstrate caspase-3 cleavage bands as early as 2 h after glucose treatment, which lasts up to 8 h. In contrast, IRS-2 transfected cells induce minimal caspase-3 cleavage (Fig. 2c) . To further confirm the relative roles of IRS-1 and IRS-2 during apoptosis, we transfected IRS-2 siRNA into IRS-1 transfected SH-SY5Y cells. IRS-2 siRNA significantly decreased IRS-2 expression in both vector (pcDNA) and IRS-1 transfected SH-SY5Y cells without affecting the IRS-1 expression level (Fig. 3a) . Glucose treatment of these cells induces caspase-3 cleavage, and IRS-1 overexpression does not prevent glucose-induced caspase-3 cleavage (Fig. 3b) or apoptosis (Fig. 3c) .
FAK and Akt degradation contributes to neuronal apoptosis [16] . FAK is involved in anoikis (apoptosis due to cell detachment from the substrate) [29, 30] , and the PI 3-kinase/Akt pathway is critical for survival of many cell types [31] . Vector or HA-IRS-1 transfected SH-EP cells These experiments are repeated at least three times and a representative result is shown in duplicate. Con: control; Glu: glucose show time-dependent degradation of both FAK and Akt following glucose treatment (Fig. 4 ]. In agreement with the apoptosis and caspase-3 cleavage data, HA-IRS-2 transfection inhibits glucose-induced FAK and Akt degradation. This effect is specific to FAK and Akt, since glucose treatment does not affect levels of ERK1/2 or actin (Fig. 4) . Unlike IRS-1 degradation we were not able to detect any fragments of FAK or Akt degradation. It is possible that the fragments are too small to be detected or do not have the antigenic sites the antibodies can recognize. These results clearly show that IRS-2, but not IRS-1, specifically protects SH-EP cells from glucose-induced apoptosis and the degradation of FAK and Akt.
IRS-1 and IRS-2 degradation are mediated by different mechanisms
We speculate that the differential roles of IRS-1 and IRS-2 in neural cells could be due, in part, to distinct mechanisms of degradation. When serum starved SH-EP cells are treated with 300 mM glucose, both IRS-1 and IRS-2 exhibit time-dependent degradation. However, IRS-1 is degraded much earlier than IRS-2 (Fig. 5a ). IRS-1 shows 48% degradation by 2 h and almost 80% by 8 h, compared to 18% by 2 h and 48% by 8 h for IRS-2. When analyzed using a higher percentage SDS-PAGE, IRS-1 degradation is accompanied by the appearance of a smaller fragment (Fig. 5a, lower panel) . IRS-1 levels decrease between 1 and 2 h after glucose treatment (Fig. 5b) and a smaller fragment of IRS-1 appears at 1 h after glucose treatment (Fig. 5b, arrowhead) , which coincides with caspase-3 cleavage. The cleavage of IRS-1 and caspase-3 is followed by FAK and Akt degradation, which precedes apoptosis (Fig. 1a) .
Since IRS-1 and IRS-2 display different patterns of degradation (as indicated by the mobility shift in IRS-2 but not in IRS-1), possible mechanisms involved in IRS degradation were examined. This experiment employed inhibitors of caspases (ZVAD), proteasome (MG132), and calpain (calpain inhibitor III). Based on the results from Fig. 5 , we chose 2 and 4 h time points for IRS-1 transfected cells and 8 h for IRS-2 transfected cells to examine the degradation. IRS-1 degradation is blocked by ZVAD and a caspase-3 specific inhibitor (data not shown) at 2 and 4 h after glucose treatment (Fig. 6, left panel) . MG132 delays but does not prevent degradation and calpain inhibition has little effect on IRS-1 degradation. As expected the results are similar for FAK and Akt degradation; ZVAD inhibits FAK and Akt degradation, while MG132 delays and calpain inhibition has little effect on degradation (Fig. 6, left panel) . IRS-2 degradation was examined at 8 h after glucose treatment (Fig. 6, right panel) . In contrast to IRS-1, IRS-2 degradation is blocked by MG132 and the calpain inhibitor (Fig. 6, right panel) . Interestingly, ZVAD is ineffective in preventing IRS-2 degradation. FAK and Akt levels are not changed by glucose treatment in IRS-2 transfected cells (Figs. 6, 1c ). These results demonstrate that during glucose-induced apoptosis, IRS-1 and IRS-2 degradation occurs through different mechanisms.
IRS-2 transfection increases IGF-I-stimulated Akt activation
IGF-I treatment activates the PI 3-K/Akt and ERK1/2 signaling pathways in NBL cells [23, 24, 32] . Therefore, we next examined the effect of IRS transfection on IGF-Istimulated Akt and ERK phosphorylation. In agreement with the previous reports, IGF-I treatment stimulates the phosphorylation of Akt, at both Ser 473 and Thr 308 , and ERK1 and ERK2 (Fig. 7) . IRS-1 transfection produces no detectable changes in IGF-I-induced phosphorylation of Akt and ERK (Fig. 7) . In contrast, IGF-I-stimulated Akt activation significantly increases in IRS-2 transfected cells (Fig. 7) . IGF-I-stimulated ERK phosphorylation is not affected by IRS-2 transfection (Fig. 7) .
Discussion
Many of the biological effects of IGF-I are mediated by IGF-IR-dependent phosphorylation of IRS proteins. Despite structural and biochemical similarities, IRS-1 and IRS-2 regulate distinctly different cellular responses [5, 6] . The current results indicate a major role of IRS-2 over IRS-1 in the prevention of glucose-mediated apoptosis in human NBL cells. These data also suggest that different pathways involved in IRS degradation are responsible for the distinct ability of IRS-2 to support cell survival. We previously demonstrated that both glucose and mannitol induce apoptosis in SH-SY5Y and SH-EP NBL cells [13, 16] . However, high concentrations of mannitol are needed to induce apoptosis [13] , and even at high concentrations, cell death is considerably higher with equiosmolar glucose than with mannitol, indicating that glucose induces cell death independent of an osmolar effect [12] . In agreement with apoptosis prevention, IRS-2, not IRS-1, transfection enhanced IGF-I-mediated Akt activation.
The current report demonstrates that IRS-2, but not IRS-1, plays a major role in the survival of SH-EP NBL cells following glucotoxicity. IRS-2 transfection into SH-EP cells prevents glucose-mediated apoptosis and caspase cleavage, while IRS-1 transfection has little effect. Several reports suggest distinct anti-apoptotic roles of IRS proteins in numerous cell types despite their structural similarities. IRS-2, but not IRS-1, plays a critical role in the maturation and survival of photoreceptor cells in murine retina [33] . In brown adipocytes, IRS-1, IRS-2, and IRS-3 mediate the antiapoptotic effect of IGF-I, with IRS-1 being most effective [10] . Insulin fails to rescue serum-starvation-induced apoptosis in neonatal hepatocytes lacking IRS-2 [33] . Adenovirus-mediated expression of IRS-2 protects a pancreatic b-cell line, INS-1, against fatty acid-induced apoptosis [34] . In addition, reducing endogenous IRS-2 using siRNA in INS-1 cells increased basal and fatty acidinduced apoptosis threefold. In our current report, reducing IRS-2 expression by siRNA did not affect the basal apoptosis in SH-SY5Y cells, and IRS-1 overexpression could not rescue glucose-induced caspase-3 cleavage and apoptosis. We speculate that the lack of the effect of IRS-2 siRNA on basal apoptosis is due to the high expression of IGF-IR in SH-SY5Y cells [24] , which can activate survival signals through other mechanisms [35, 36] . The unique anti-apoptotic role of IRS-2 may be a characteristic of tumor cells, as IRS-2 expression appears critical for tumorigenicity [37, 38] . IRS-2 is overexpressed in two different animal models of hepatocarcinogenesis and also in human carcinomas [8] . We also reported that only tumorigenic N cells express IRS-2, whereas non-tumorigenic S cells express IRS-1 [24] . These reports and ours suggest that different isoforms of IRS have distinct anti-apoptotic effects depending on the specific cell type used.
Protein degradation is a common feature of apoptosis. We previously reported IRS-1, FAK, and Akt, which all play important roles in cell survival [1, 39, 40] , are degraded during SH-EP cell apoptosis [16, 25, 41] . In the current report, we show that IRS-1 and IRS-2 are also degraded during glucose-induced apoptosis. Interestingly, the degradation patterns of IRS-1 and IRS-2 are different (Fig. 4) , and lactacystin (data not shown) delay, but do not prevent, IRS-1 degradation. In contrast, IRS-2 degradation involves a mobility shift typical of serine/threonine phosphorylation. MG132 and the inhibitor of calcium-dependent cysteine protease calpain [42] , but not ZVAD, inhibit IRS-2 degradation. ZVAD is also less effective in preventing mannitol and glucose-induced IRS-2 degradation in SH-SY5Y cells (B. Kim, unpublished data), which express only IRS-2 [24] .
Studies show that various proteases are implicated in IRS degradation. IRS-1 and IRS-2 are degraded by caspase-10 during mammary epithelial cell apoptosis, regulated by the MAPK pathway [43] . IRS-1 cleavage during this process produces a small fragment, even though it has a lower molecular weight than our study [43] . Calpain inhibitor, but not caspase or proteasome inhibitors, prevents IRS-1 degradation during thapsigargin-induced apoptosis in human prostate epithelial cells [44] . We previously demonstrated that caspase inhibition prevents IRS-1 degradation during mannitol, but not okadaic acid, induced apoptosis in SH-EP cells [25] . Chronic exposure of INS-1 cells to glucose or IGF-I decreases IRS-2 expression, which is accompanied by a mobility shift and Ser/Thr phosphorylation [44] . Ser/Thr phosphorylation and subsequent degradation of IRS-2 are prevented by the mTOR inhibitor rapamycin and the proteasome inhibitor lactacystin [45] . Though there are many reports concerning the differential degradation of either IRS-1 or IRS-2 during apoptotic stimuli in specific cell types, few studies directly compare IRS-1 and IRS-2 degradation in the same cellular environment. Our results clearly demonstrate that IRS-1 undergoes rapid degradation primarily through caspase activation, while IRS-2 degradation involves proteasome and calpain activation during NBL apoptosis. We speculate reduced susceptibility to caspases renders IRS-2 more resistant to degradation and provides better anti-apoptotic capability by protecting the degradation of downstream signaling proteins such as FAK and Akt (see below). Our results may explain the different effects of IRS isoforms during apoptosis of different cell types [10, 33, 34, 46] .
In response to excess glucose, FAK and Akt are degraded in parallel with IRS-1 in IRS-1 transfected SH-EP cells but remain intact in IRS-2 transfected cells. We previously demonstrated the importance of FAK and Akt during mannitol and okadaic acid-induced apoptosis in SH-EP cells [16, 41] . FAK is an important member of focal adhesion complexes, which transmit signals from the extracellular matrix to the cytoplasm [39] . IRS-1 binds and activates FAK [47] and disruption of FAK signaling results in apoptosis [48] , while overexpression of FAK prevents apoptosis, especially anoikis [29, 30] . The PI 3-kinase/Akt pathway is critical for the survival of many cell types [40, 49] . Dominant negative Akt prevents IGF-I mediated survival in Schwann cells [26] , and PTEN overexpression, which decreases Akt phosphorylation [50] , enhances mannitol-induced NBL cell apoptosis [51] . In agreement with our previous reports [16, 41] , FAK and Akt are degraded during glucose-induced apoptosis. IRS-1 degradation and caspase-3 cleavage are preceded by FAK and Akt degradation prior to the detection of apoptosis. Similar to our results, a recent report showed FAK cleavage during oxidative stress-induced apoptosis in HeLa cells [52] . In contrast, FAK and Akt remain intact up to 8 h following glucose treatment even when IRS-2 levels are decreased to 50% of control level. These results suggest that caspasemediated rapid degradation of IRS-1 destabilizes FAK and Akt, resulting in their degradation and facilitation of cell detachment and apoptosis.
IRS-2, but not IRS-1, transfection enhances IGF-Istimulated PI 3-K/Akt signaling in SH-EP cells. Akt is a serine/threonine kinase, which plays a critical role in many cellular responses, including glucose metabolism, apoptosis, and cell migration [31] . Integrin ligation and growth factor activation of Akt require the phosphorylation of both Ser 473 and Thr 308 through a PI 3-kinase-mediated pathway [53, 54] . Activated Akt regulates proteins involved in cell survival/apoptosis including caspases and Bcl family proteins [40, 49] . PI 3-K/Akt signaling is critical for IGF-I's anti-apoptotic effect in vitro and in vivo [26, 51] , as well as for cell motility [26, 51] and neurite outgrowth [55] . The preferential phosphorylation (i.e. activation) of Akt in IRS-2 transfected cells correlates well with our results suggesting a distinct anti-apoptotic role of IRS-2 following glucotoxicity in human NBL cells. Interestingly, IRS-2 expression minimally affects ERK1/2 activation. This agrees with our previous report demonstrating that a ShcGrb2 complex activates ERK1/2, whereas IRS-2 activates PI 3-K/Akt signaling [32] . Shc phosphorylation is very low in SH-EP cells, and IRS-1 or IRS-2 expression does not change basal or IGF-I-induced Shc phosphorylation (data not shown).
In summary, we demonstrate that IRS-2, but not IRS-1, prevents glucose-mediated apoptosis in human NBL cells. We speculate that distinct degradation pathways involving different proteases for IRS-1 and IRS-2 are responsible for the unique anti-apoptotic role of IRS-2. We also demonstrate that IRS-2 transfection increases IGF-I-mediated Akt activation. These results support the hypothesis that IRS-2, not IRS-1, is the major signaling molecule for survival signaling in NBL cells and provide a rationale for developing new therapeutic compounds targeting IRS-2 in NBL treatment.
